JOINT FILING AGREEMENT
Exhibit
3
In
accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of
1934, as
amended, each of the undersigned Reporting Persons hereby agrees to the
joint
filing, along with all other such Reporting Persons, on behalf of each
of them
of a statement on Schedule 13G (including amendments thereto) with respect
to
the Common Stock, $0.001 par value, of Replidyne, Inc., and that this
Agreement
be included as an Exhibit to such joint filing. This Agreement may be
executed
in any number of counterparts, all of which taken together shall constitute
one
and the same instrument.
IN
WITNESS WHEREOF, each of the undersigned hereby executes this Agreement
as of
this 10th day of May, 2007.
|
|||
|
By:
|
X.
X. Xxxx & Co., L.L.C., as
managing
member
|
|
|
|
|
|
|
|
By:
|
/s/ Xxxx
Xxxxxxx
Xxxx
Xxxxxxx
Managing
Director
|
|
D.
E. Shaw Composite Portfolios, L.L.C.
|
||
|
By:
|
X.
X. Xxxx & Co., L.L.C., as
managing
member
|
|
|
|
|
|
|
|
By:
|
/s/ Xxxx
Xxxxxxx
Xxxx
Xxxxxxx
Managing
Director
|
X. X. Xxxx & Co., L.L.C. | ||
|
|
|
By: | /s/ Xxxx Xxxxxxx | |
Xxxx
Xxxxxxx
Managing
Director
|
X. X. Xxxx & Co., L.P. | ||
|
|
|
By: | /s/ Xxxx Xxxxxxx | |
Xxxx
Xxxxxxx
Managing
Director
|
Xxxxx X. Xxxx | ||
|
|
|
By: | /s/ Xxxx Xxxxxxx | |
Xxxx
Xxxxxxx
Attorney-in-Fact
for Xxxxx X. Xxxx
|